Partner news
News
Partner news
RefleXion Raises $100 Million for Cancer Treatment Commercialization
Read full storyPartner news
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies
Read full storyPartner news
Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform
Read full storyPartner news
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing
Read full storyPartner news
BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140
Read full storyPartner news
Joint Purification Systems, Inc. Announces $7.8 Million Series A Financing
Read full storyPartner news
ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications
Read full storyPartner news
ViaCyte Awarded NIH SBIR Grant to Support In Vitro Development of Stem Cell-Derived Functional Human Pancreatic Beta Cells
Read full storyPartner news
RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment
Read full storyPartner news
Aelix Therapeutics appoints HIV expert as CMO
Read full storyPartner news
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer
Read full storyPartner news
Padlock Therapeutics Assembles Scientific Advisory Board with World Leaders in PAD Enzyme Biology and Autoimmune Disease
Read full storyPartner news
Johnson & Johnson Innovation Commits $15M to Vivo Capital
Read full storyPartner news